GB202104082D0 - Camellia nitidissima chi extracted and purified l-theanine oral preparation for preventing novel coronavirus pneumonia and preparation method and application - Google Patents

Camellia nitidissima chi extracted and purified l-theanine oral preparation for preventing novel coronavirus pneumonia and preparation method and application

Info

Publication number
GB202104082D0
GB202104082D0 GBGB2104082.9A GB202104082A GB202104082D0 GB 202104082 D0 GB202104082 D0 GB 202104082D0 GB 202104082 A GB202104082 A GB 202104082A GB 202104082 D0 GB202104082 D0 GB 202104082D0
Authority
GB
United Kingdom
Prior art keywords
preparation
theanine
purified
extracted
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB2104082.9A
Other versions
GB2594792B (en
GB2594792A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaoguan University
Original Assignee
Shaoguan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaoguan University filed Critical Shaoguan University
Publication of GB202104082D0 publication Critical patent/GB202104082D0/en
Publication of GB2594792A publication Critical patent/GB2594792A/en
Application granted granted Critical
Publication of GB2594792B publication Critical patent/GB2594792B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
GB2104082.9A 2020-03-30 2021-03-24 Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application Active GB2594792B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010238228.XA CN111437245A (en) 2020-03-30 2020-03-30 Camellia chrysantha L-theanine oral preparation for preventing novel coronavirus pneumonia and preparation method and application thereof

Publications (3)

Publication Number Publication Date
GB202104082D0 true GB202104082D0 (en) 2021-05-05
GB2594792A GB2594792A (en) 2021-11-10
GB2594792B GB2594792B (en) 2023-09-27

Family

ID=71649306

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2104082.9A Active GB2594792B (en) 2020-03-30 2021-03-24 Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application

Country Status (2)

Country Link
CN (1) CN111437245A (en)
GB (1) GB2594792B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111991414B (en) * 2020-07-30 2023-09-01 福建美拉得康生物制药有限公司 Application of beta-chitosamine in preparing medicament for preventing and treating new coronapneumovirus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767714B2 (en) * 2002-02-18 2010-08-03 Ajinomoto Co., Inc. Method of preventing infectious diseases
CN1237981C (en) * 2003-12-31 2006-01-25 北京科信必成医药科技发展有限公司 Ginkgoleaf oral cavity disintegrating tablet and its preparation method
US8465782B2 (en) * 2006-09-21 2013-06-18 Immune Guard, LLC Methods and materials for reducing risk of cold and/or flu
CN102525976B (en) * 2011-12-14 2013-05-22 天津药物研究院药业有限责任公司 Method for preparing strontium ranelate orally disintegrating tablets with fluidized bed

Also Published As

Publication number Publication date
GB2594792B (en) 2023-09-27
CN111437245A (en) 2020-07-24
GB2594792A (en) 2021-11-10

Similar Documents

Publication Publication Date Title
NZ617104A (en) Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
EP3952784A4 (en) Dental aligners and procedures for aligning teeth
NZ616806A (en) Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
GB202104082D0 (en) Camellia nitidissima chi extracted and purified l-theanine oral preparation for preventing novel coronavirus pneumonia and preparation method and application
WO2010110545A3 (en) Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
CA208374S (en) Mouth tape for treating sleep disorders
EP4100019A4 (en) Method for treating coronavirus infections
CA208377S (en) Mouth tape for treating sleep disorders
MX2015007879A (en) Oral care composition.
IL277315B (en) Methods and composition for treating coronavirus infection
EP4031064A4 (en) Oral hygiene system and method of use
IL277423A (en) Devices and methods for low latency oral authentication
MX2013002956A (en) Arylosulfonamides for the treatment of cns diseases.
EP4122483A4 (en) Oral pharmaceutical composition
EP4126056A4 (en) New compositions for oral or nasal use
IL180367A0 (en) Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection
GB202104084D0 (en) Camellia nitidissima chi extracted theaflavin medicament for resisting novel coronavirus and preparation method and application thereof
CA208376S (en) Mouth tape for treating sleep disorders
IL307872A (en) Novel compositions and methods for treating coronavirus infections
EP4132503A4 (en) Methods for treatment of coronavirus infections
EP4120863A4 (en) Method for treatment of coronavirus infection
EP4073318C0 (en) Machine and method for stabilising a ballast track
EP2575457A4 (en) Oral pharmaceutical composition of duloxetine
UA116105C2 (en) Inactivated mycobacteria for oral use in the prevention of tuberculosis
EP3935215C0 (en) Track construction machine and method for stabilizing a ballast bed